In addition, the xenografts with parental HCC827 lung cancer cells developed the smallest tumors, whereas xenografts with SRSF1-knockdown Gefitinib-resistant cells developed smaller tumors as compared to controls (Fig. 7f), and grew much slower than controls as well (Fig. 7g). The gene discussed is SRSF1; the disease is lung cancer.